,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,348,2,3,,4254198,5326397,Inactive,66360678.0,,,,Glucocerebrosidase-p2,Confirmatory,,
1,357,2,1,,4254198,5326397,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
2,410,1,5,,4254198,5326397,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
3,411,2,1,,4254198,5326397,Active,160794.0,,3.9811,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
4,444,1,1,,4254198,5326397,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
5,445,3,1,,4254198,5326397,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
6,446,1,1,,4254198,5326397,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
7,447,1,1,,4254198,5326397,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
8,448,1,2,,4254198,5326397,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
9,450,1,2,,4254198,5326397,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
10,451,1,2,,4254198,5326397,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
11,526,1,1,,4254198,5326397,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
12,530,1,1,,4254198,5326397,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
13,584,1,3,,4254198,5326397,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
14,585,1,4,,4254198,5326397,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
15,587,1,5,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
16,588,1,4,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
17,589,1,3,,4254198,5326397,Active,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
18,590,1,3,,4254198,5326397,Active,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
19,591,1,4,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
20,592,1,6,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
21,593,1,4,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
22,594,1,4,,4254198,5326397,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
23,595,1,3,,4254198,5326397,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
24,596,1,2,,4254198,5326397,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
25,597,1,3,,4254198,5326397,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
26,603,1,2,,4254198,5326397,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
27,605,1,2,,4254198,5326397,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
28,607,1,3,,4254198,5326397,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
29,630,1,1,,26653566,5326397,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
30,662,1,1,,4254198,5326397,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
31,875,1,2,,4254198,5326397,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
32,880,2,1,,50109558,5326397,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
33,880,2,1,,50109558,5326397,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
34,881,2,2,,4254198,5326397,Inactive,317373425.0,247.0,3.9811,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
35,883,1,3,,4254198,5326397,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
36,884,1,2,,4254198,5326397,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
37,885,1,2,,4254198,5326397,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
38,886,1,2,,4254198,5326397,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
39,886,1,2,,4254198,5326397,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
40,887,1,2,,4254198,5326397,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
41,889,1,3,,4254198,5326397,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
42,891,1,2,,4254198,5326397,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
43,892,1,2,,4254198,5326397,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
44,893,1,2,,4254198,5326397,Active,122921310.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
45,893,1,2,,4254198,5326397,Active,122921311.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
46,894,2,1,,50109558,5326397,Inconclusive,31542939.0,3248.0,3.1623,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
47,899,1,2,,4254198,5326397,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
48,900,1,3,,4254198,5326397,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
49,902,1,2,,4254198,5326397,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
50,912,1,2,,4254198,5326397,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
51,914,1,3,,4254198,5326397,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
52,915,1,3,,4254198,5326397,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
53,923,1,2,,4254198,5326397,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
54,924,1,2,,4254198,5326397,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
55,925,1,2,,4254198,5326397,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
56,926,1,2,,4254198,5326397,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
57,938,1,2,,4254198,5326397,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
58,940,1,2,,26653566,5326397,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
59,995,1,2,,4254198,5326397,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
60,1030,2,1,,50109558,5326397,Inconclusive,30582681.0,216.0,7.0795,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
61,1379,1,2,,50109558,5326397,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
62,1422,1,1,,26653566,5326397,Active,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
63,1452,1,1,,4254198,5326397,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
64,1457,1,1,,50109558,5326397,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
65,1458,1,1,,50109558,5326397,Inconclusive,10937869.0,6607.0,4.4668,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
66,1471,2,1,,4254198,5326397,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
67,1476,2,1,,50109558,5326397,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
68,1478,2,1,,50109558,5326397,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
69,1851,1,2,,4254198,5326397,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
70,1851,1,2,1.0,4254198,5326397,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
71,1851,1,2,2.0,4254198,5326397,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
72,1851,1,2,3.0,4254198,5326397,Inactive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
73,1851,1,2,4.0,4254198,5326397,Inactive,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
74,1851,1,2,5.0,4254198,5326397,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
75,1948,1,1,,50109558,5326397,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
76,2326,1,1,,50109558,5326397,Inactive,194352380.0,,1.122,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
77,3217,3,3,,103232794,5326397,Unspecified,,,,,Association constant for binding to AATT 28-mer AATT hairpin,Other,11472203.0,
78,3218,3,3,,103232794,5326397,Unspecified,,,,,Kinetically Defined Association Constant for 28-mer AATT hairpin.,Other,11472203.0,
79,3219,4,2,,103232794,5326397,Unspecified,,,,,Reaction Rate Parameter for 28-mer AATT hairpin,Other,11472203.0,
80,3220,4,2,,103232794,5326397,Unspecified,,,,,Reaction Rate Parameter for 28-mer AATT hairpin,Other,11472203.0,
81,7680,6,2,,103232794,5326397,Active,,,9.5,IC50,Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line,Confirmatory,11170623.0,
82,9817,6,2,,103232794,5326397,Active,,,12.0,IC50,Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line,Confirmatory,11170623.0,
83,9844,3,3,,103232794,5326397,Unspecified,,,,,Association constant for binding to AATT duplex,Other,11472203.0,
84,31892,3,3,,103232794,5326397,Unspecified,,,,,Thermal denaturation in alternating poly(dA-dT)poly(dA-dT) homopolymer (AT),Other,8510102.0,
85,31893,3,3,,103232794,5326397,Unspecified,,,,,Thermal denaturation in sonicated poly(dA)-poly(dT) homopolymer (AT),Other,8510102.0,
86,47483,6,2,,103232794,5326397,Active,,,26.5,IC50,Antitumor activity of compound for 96-h exposure in CH1 human ovarian cell line,Confirmatory,11170623.0,
87,54272,3,3,,103232794,5326397,Unspecified,,,,,Intrinsic association constant for reversible binding of compounds to calf thymus DNA at 20 degree C,Other,7527862.0,
88,54423,4,1,,103232794,5326397,Unspecified,,,,,Denaturation temperature change on binding to AT to poly (dA)-poly(dT),Other,1738139.0,
89,54424,4,1,,103232794,5326397,Unspecified,,,,,Denaturation temperature change on binding on GC to poly(dGC)-poly(dGC),Other,1738139.0,
90,54426,4,1,,103232794,5326397,Unspecified,,,,,Denaturation temperature change on binding to calf thymus DNA,Other,1738139.0,
91,54427,4,1,,103232794,5326397,Unspecified,,,,,DNA binding activity as denaturation temperatures on AT to poly (dA)-poly(dT) normalized to ethidium bromide,Other,1738139.0,
92,54984,3,3,,103232794,5326397,Unspecified,,,,,Thermal denaturation in sonicated calf thymus DNA (CT DNA),Other,8510102.0,
93,57051,7,1,,103232794,5326397,Active,,,,,Compound was tested to determine equilibrium association constant on calf thymus DNA by fluorescence spectrometric analysis.,Other,8941394.0,
94,57391,4,1,,103232794,5326397,Unspecified,,,,,DNA binding activity as denaturation temperature on GC to poly (dGC)-poly(dGC) normalized to ethidium bromide,Other,1738139.0,
95,72882,3,3,,103232794,5326397,Unspecified,,,,,Thermal denaturation in alternating poly(dG-dC)-poly(dG-dC) homopolymer (GC),Other,8510102.0,
96,130327,5,2,,103232794,5326397,Inactive,,,,,Tested for percentage increase in lifespan of drug-treated tumor-bearing animals when treated at optimal dose; NA=Inactive,Other,7527862.0,
97,133624,3,4,,103232794,5326397,Unspecified,,,,,Tested for the intraperitoneal optimal dose of 0.1 mL in tumor cells,Other,7527862.0,
98,150501,6,2,,103232794,5326397,Active,,,1.2,IC50,Concentration of the drug to inhibit wild type P388 murine leukemia cell growth in culture,Confirmatory,7527862.0,
99,202836,6,2,,103232794,5326397,Unspecified,,,100.0,IC50,Antitumor activity of compound for 96-h exposure in SKOV-3 human ovarian cell line,Confirmatory,11170623.0,
100,212741,3,5,,103232794,5326397,Unspecified,,,,,Inhibition of purified telomerase of Euplotes aediculatus at 50 uM,Other,15177454.0,
101,212743,3,5,,103232794,5326397,Unspecified,,,,,Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM,Other,15177454.0,
102,212744,3,5,,103232794,5326397,Unspecified,,,,,Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM,Other,15177454.0,
103,212902,4,10,,103232794,5326397,Unspecified,6226780.0,7015.0,,,Inhibition of human telomerase after assembly using recombinant hTR and hTERT at 50 uM,Other,15177454.0,
104,212903,3,10,,103232794,5326397,Unspecified,6226780.0,7015.0,,,Inhibition of human telomerase before assembly using recombinant hTR and hTERT at 50 uM,Other,15177454.0,
105,218907,3,3,,103232794,5326397,Unspecified,,,,,Association constant (Ka) with DNA dodecamer d(CCGGAATTCCGG) was determined,Other,10612581.0,
106,225935,3,3,,103232794,5326397,Unspecified,,,,,Association constant for binding to poly[d(A-T)].,Other,11472203.0,
107,233938,3,3,,103232794,5326397,Unspecified,,,,,Ratio between poly-dAdT and poly-dGdC binding,Other,8510102.0,
108,242163,6,2,,103232794,5326397,Active,,,1.0,IC50,Inhibitory concentration required to displace DNA-bound ethidium bromide molecules bound to CA12 (5''-CGCGAATTCGCG)2,Confirmatory,15341939.0,
109,242164,6,2,,103232794,5326397,Unspecified,,,20.0,IC50,Inhibitory concentration required to displace DNA-bound ethidium bromide molecules bound to CT12 (5''-CGTAGCGCTACG)2,Confirmatory,15341939.0,
110,282344,8,7,,103232794,5326397,Inactive,23831360.0,471.0,,IC50,Inhibition of human AICAR Tfase,Confirmatory,15615517.0,
111,304717,3,5,,103232794,5326397,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as thermal stability in BPE buffer at 2 uM,Other,18052116.0,
112,304718,3,5,,103232794,5326397,Unspecified,,,,,Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer at 12 uM,Other,18052116.0,
113,304719,3,5,,103232794,5326397,Unspecified,,,,,Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer containing 0.1 M NaCl at 12 uM,Other,18052116.0,
114,394419,3,4,,103232794,5326397,Active,,,,,Antiproliferative activity against human MCF7 cells at 0.1 to 100 uM after 72 hrs by MTT assay,Other,19231203.0,
115,394430,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at G0/G1 phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
116,394432,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at G0/G1 phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
117,394434,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at S phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
118,394436,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at S phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
119,394438,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
120,394440,3,4,,103232794,5326397,Unspecified,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
121,394442,3,4,,103232794,5326397,Inactive,,,,,Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by propidium iodide-based flow cytometry,Other,19231203.0,
122,395133,3,3,,103232794,5326397,Unspecified,,,,,Binding affinity to poly(dA).poly(dT) duplex DNA assessed as ratio of KA to KB by ESI-MS analysis,Other,18403056.0,
123,469604,3,4,,103232794,5326397,Unspecified,,,,,Binding affinity to duplex DNA dA22.dT22 assessed as change in melting temperature at 3 uM by UV analysis at 260 nm,Other,19651510.0,
124,477016,3,3,,103232794,5326397,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as temperature required to cause 50% of DNA denatured at 10 uM by thermal denaturation assay,Other,20064676.0,
125,477017,3,3,,103232794,5326397,Inconclusive,,,,,Displacement of ethidium bromide from calf thymus DNA assessed as decrease of fluorescence of bound ethidium bromide by fluorometric assay,Other,20064676.0,
126,512633,2,3,,103232794,5326397,Active,,,,,Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy,Other,16408022.0,
127,536054,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MDA-N cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
128,536055,2,11,,103232794,5326397,Unspecified,400274.0,5604.0,,,Activation of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
129,536055,2,11,,103232794,5326397,Unspecified,547915.0,5605.0,,,Activation of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
130,536056,2,11,,103232794,5326397,Unspecified,400274.0,5604.0,,,Inhibition of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
131,536056,2,11,,103232794,5326397,Unspecified,547915.0,5605.0,,,Inhibition of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
132,536057,2,11,,103232794,5326397,Unspecified,118572669.0,5607.0,,,Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
133,536058,2,11,,103232794,5326397,Unspecified,118572669.0,5607.0,,,Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control,Other,20965737.0,
134,536059,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human CCRF-CEM cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
135,536060,2,5,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HL-60(TB) cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
136,536061,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human K562 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
137,536062,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MOLT4 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
138,536063,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human RPMI8266 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
139,536064,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SR cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
140,536065,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human A549 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
141,536066,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human EKVX cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
142,536067,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HOP62 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
143,536068,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HOP92 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
144,536069,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI-H226 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
145,536070,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI-H23 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
146,536071,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI-H322M cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
147,536072,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI-H460 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
148,536073,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI-H522 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
149,536146,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human COLO205 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
150,536147,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HCC2998 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
151,536148,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HCT116 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
152,536149,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HCT15 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
153,536150,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human HT-29 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
154,536151,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human KM12 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
155,536152,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SW620 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
156,536153,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SF268 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
157,536154,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SF295 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
158,536155,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SF539 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
159,536156,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SNB19 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
160,536157,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SNB75 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
161,536158,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human U251 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
162,536159,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human LOXIMVI cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
163,536160,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MALME-3M cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
164,536161,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human M14 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
165,536162,1,5,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MDA-MB-435 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
166,536163,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SK-MEL-2 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
167,536164,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SK-MEL-28 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
168,536165,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SK-MEL-5 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
169,536166,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human UACC257 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
170,536167,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human UACC62 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
171,536168,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human IGROV1 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
172,536169,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human OVCAR-3 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
173,536170,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human OVCAR4 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
174,536171,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human OVCAR5 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
175,536172,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human OVCAR8 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
176,536173,1,5,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human NCI/ADR-RES cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
177,536174,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SKOV3 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
178,536175,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human 786-0 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
179,536176,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human A498 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
180,536177,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human ACHN cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
181,536178,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human Caki1 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
182,536179,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human RXF393 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
183,536180,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human SN12C cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
184,536181,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human TK10 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
185,536182,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human UO31 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
186,536183,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human PC3 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
187,536184,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human DU145 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
188,536185,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MCF7 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
189,536186,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human MDA-MB-231 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
190,536187,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human Hs 578T cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
191,536188,2,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human BT549 cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
192,536189,1,4,,103232794,5326397,Unspecified,,,,,Cytotoxicity against human T47D cells at 10 uM assessed as cell growth relative to control,Other,20965737.0,
193,569089,4,2,,103232794,5326397,Active,,,5.7,GI50,Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
194,569090,4,2,,103232794,5326397,Unspecified,,,91.7,GI50,Cytotoxicity against human NCI-H358 cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
195,569091,4,2,,103232794,5326397,Unspecified,,,84.0,GI50,Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
196,569092,5,3,,103232794,5326397,Unspecified,,,132.5,GI50,Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
197,569093,4,2,,103232794,5326397,Unspecified,,,115.7,GI50,Cytotoxicity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
198,569094,4,2,,103232794,5326397,Unspecified,,,112.0,GI50,Cytotoxicity against human AGS cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
199,569095,5,2,,103232794,5326397,Unspecified,,,191.5,GI50,Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
200,569096,4,2,,103232794,5326397,Unspecified,,,157.5,GI50,Cytotoxicity against MDCK cells after 72 hrs by MTT assay,Confirmatory,21227551.0,
201,569115,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
202,569116,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
203,569117,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
204,569118,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
205,569119,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
206,569120,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
207,569121,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
208,569122,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
209,569123,1,4,,103232794,5326397,Unspecified,,,,,Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%),Other,21227551.0,
210,689263,4,1,,103232794,5326397,Unspecified,,,51.31,IC50,Cytotoxicity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,22959518.0,
211,689264,4,1,,103232794,5326397,Active,,,32.43,IC50,Cytotoxicity against human HL60 cells after 72 hrs by MTT assay,Confirmatory,22959518.0,
212,689265,4,1,,103232794,5326397,Active,,,15.42,IC50,Cytotoxicity against human U937 cells after 72 hrs by MTT assay,Confirmatory,22959518.0,
213,1227433,1,1,,103232794,5326397,Active,,,19.5,IC50,Inhibition of Escherichia coli DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 15 mins by agarose gel electrophoresis,Confirmatory,25083189.0,
214,1227434,1,1,,103232794,5326397,Active,12644118.0,7150.0,22.86,IC50,Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 30 mins by agarose gel electrophoresis,Confirmatory,25083189.0,
215,1227435,1,1,,103232794,5326397,Active,13959709.0,7153.0,28.92,IC50,Inhibition of human DNA topoisomerase-2 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 30 mins by agarose gel electrophoresis,Confirmatory,25083189.0,
216,1227436,1,1,,103232794,5326397,Unspecified,12644118.0,7150.0,,,Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation at 50 uM after 30 mins by agarose gel electrophoresis relative to control,Other,25083189.0,
217,1227437,1,1,,103232794,5326397,Inactive,84028817.0,,,,Inhibition of Escherichia coli DNA gyrase using relaxed pBAD-GFPuv plasmid DNA as substrate at 1 to 50 uM after 30 mins by agarose gel electrophoresis,Other,25083189.0,
218,1227437,1,1,,103232794,5326397,Inactive,84028820.0,,,,Inhibition of Escherichia coli DNA gyrase using relaxed pBAD-GFPuv plasmid DNA as substrate at 1 to 50 uM after 30 mins by agarose gel electrophoresis,Other,25083189.0,
219,1227439,1,1,,103232794,5326397,Unspecified,,,,,Binding affinity to dA60.dT60 DNA (unknown origin) assessed as change in melting temperature at 10 uM by UV-Vis spectrophotometric analysis,Other,25083189.0,
220,1227442,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microbroth dilution method,Other,25083189.0,
221,1227443,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 33591 after 24 hrs by microbroth dilution method,Other,25083189.0,
222,1227444,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microbroth dilution method,Other,25083189.0,
223,1227445,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microbroth dilution method,Other,25083189.0,
224,1227446,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Escherichia coli K-12 after 24 hrs by microbroth dilution method,Other,25083189.0,
225,1227447,1,1,,103232794,5326397,Unspecified,,,,,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microbroth dilution method,Other,25083189.0,
226,1259407,1,1,,363906339,5326397,Inactive,,,,,CCRIS mutagenicity studies,Other,,
227,1259416,1,2,,340085111,5326397,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
228,1259421,1,1,,340085111,5326397,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
